Stellest AI analyzes your patient's clinical data in seconds — predicting myopia progression, estimating Stellest Lens efficacy, and generating comprehensive reports that help families understand the urgency of treatment.
Interactive Preview
See how myopia progression could unfold — with and without Stellest Lens intervention.
* Simplified estimate based on BISCUIT clinical data. Use the full AI analysis for evidence-based clinical decisions.
Clinical Evidence
Based on the BISCUIT clinical trial and WHO global myopia prevalence data.
Workflow
Input patient demographics, refractive data (Sph/Cyl/Axis), axial length measurements, lifestyle factors, and treatment history.
Gemini processes clinical data against our retrospective Stellest dataset, calculating SER, progression velocity, and risk stratification.
Receive an interactive dashboard with progression charts, risk scores, treatment comparison, and a downloadable clinical PDF report.
Platform Features
Instant predictions powered by Gemini using your patient's clinical data and our Stellest retrospective dataset.
Interactive progression charts comparing treated vs untreated myopia trajectories with age-based forecasting.
Professional, printable reports with risk scores, treatment recommendations, and patient-friendly explanations.
Quantified projections of Stellest Lens benefit — diopters saved, axial length slowdown, and long-term vision outcomes.
Multi-factor risk scoring using parental myopia, age of onset, lifestyle, and biometric data to classify progression risk.
Compare patient data against our retrospective Stellest clinical dataset to contextualize where they sit on the spectrum.
High myopia is not just an inconvenience — it's a leading risk factor for permanent vision loss. Stellest AI helps you make evidence-based decisions, fast.